Pharmafile Logo
Pharmafocus logo
Advanced Search
800px-jnjioffice

New York files $2 billion lawsuit against J&J for downplaying risks of opioids in its marketing

September 18, 2020
Medical Communications new york state, opioid crisis

New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in damages for the company’s role …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 18, 2020
Medical Communications

The top ten news stories this week centre around coronavirus vaccines, with Russia signing a deal with an Indian pharma …

News
novartis_outside_1

Novartis’ Tafinlar/Mekinist combo improves five-year relapse-free survival in new Phase 3 data

September 17, 2020
Research and Development Novartis, Tafinlar, mekinist, melanoma

Novartis has unveiled promising new Phase 3 data for its combination of Tafinlar (dabrafenib) with Mekinist (trametinib) in the treatment …

News

Opdivo scores NICE recommendation in two non-small cell lung cancer indications

September 17, 2020
Sales and Marketing NICE, lung cancer, opdivo

NICE has announced its recommendation of Bristol-Myers Squibb’s blockbuster immunotherapy drug Opdivo (nivolumab) for the treatment of two non-small cell …

News
800px-vaccine_image_1

Oxford University says participant illness that halted its COVID-19 trial may not be linked to the vaccine

September 17, 2020
Research and Development coronavirus vaccines, vaccines

The illness of one of the participants in the Oxford-AstraZeneca COVID-19 vaccine trial may not have been caused by the …

News
donald_trump_29496131773

US sets out plans to distribute free coronavirus vaccines

September 17, 2020
Research and Development

The Trump administration has laid out its strategy to distribute COVID-19 vaccines for free across the US.  The Department of …

News
800px-kodak_colorplus_200_135_film_cartridge_and_box

Independent review finds no evidence of insider trading from Kodak executives before US Government pharma deal

September 17, 2020
Business Services

Kodak has been cleared of insider trading by an independent review after one of its top executives bought shares before …

News
alex_azar_-_pete_marovich-getty_images

HHS Secretary Alex Azar accused of overruling FDA on COVID-19 test quality reviews

September 16, 2020
Research and Development COVID-19, FDA, US, USA

Allegations have emerged accusing US Health and Human Services Secretary Alex Azar of overruling the FDA over the review of …

News
gettyimages-1206570416

India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine

September 16, 2020
Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine

Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …

News
800px-pfizer_finland_hq_february_13_2009

Pfizer’s coronavirus vaccine shows moderate side-effects in clinical study

September 16, 2020
Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine

Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …

News
steve_bannon_32289717844

Study that alleges COVID-19 was made in a Chinese lab originated from non-profits linked to ex-Trump advisor Steve Bannon

September 16, 2020
Research and Development China, Donald Trump, Steve Bannon, Wuhan, coronavirus

A new study that alleges COVID-19 was created in a Chinese lab was published by two non-profits that are linked …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 16, 2020
Research and Development COVID, COVID-19 vaccine, coronavirus

The coronavirus news this week focuses on AstraZeneca’s vaccine candidate, as global trials for itsmuch-hyped vaccine were halted after an …

News
lilly_building_with_american_flag_web

Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients, according to new data

September 15, 2020
Manufacturing and Production, Research and Development COVID-19, Eli Lilly, pharma, remdesivir

Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s …

News
shutter

MSD partners up with Seattle Genetics in two oncology development deals potentially worth over $4bn

September 15, 2020
Manufacturing and Production, Sales and Marketing MSD, Seattle Genetics, deal, pharma

MSD has signed two new oncology-based deals with Seattle Genetics which together could be worth up to around $4.4 billion. …

News
800px-shionogi_01

Shionogi launches Fetcroja in the UK for aerobic Gram-negative bacteria infections

September 15, 2020
Manufacturing and Production

Shionogi has announced the launch of its new antibiotic in the UK for the treatment of infections due to aerobic …

News
patrick_vallance_royal_society_cropped

UK Government’s Chief Scientific Adviser “told off” for advocating for early lockdown

September 15, 2020
Manufacturing and Production

Sir Patrick Vallance, the Chief Scientific Adviser to the UK Government, was “told off” for advocating for an early lockdown …

News
37233544_954551461372729_6659828700663513088_n_1

Avantor Clinical Services helps clinical trials stay on track

September 15, 2020
Manufacturing and Production

Biopharma and pharmaceutical companies developing treatments and vaccines have long faced operational challenges that cost time and money while draining …

News
spotlighton-aprile-cw_covid-19-and-cancer-1-img

Oncology research in the age of COVID-19

September 14, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …

Feature
shutterstock_38078521

AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review

September 14, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine

After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …

News
shutterstock_273326141

Gilead scoops up Immunomedics in deal worth $21 billion

September 14, 2020
Sales and Marketing Gilead, Immunomedics, acquisition, pharma

The Board of Directors from both companies have unanimously agreed for Gilead to acquire Immunomedics for $88 per share in …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026